372 related articles for article (PubMed ID: 12060763)
1. Regulation of alternative splicing by a transcriptional enhancer through RNA pol II elongation.
Kadener S; Fededa JP; Rosbash M; Kornblihtt AR
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8185-90. PubMed ID: 12060763
[TBL] [Abstract][Full Text] [Related]
2. Antagonistic effects of T-Ag and VP16 reveal a role for RNA pol II elongation on alternative splicing.
Kadener S; Cramer P; Nogués G; Cazalla D; de la Mata M; Fededa JP; Werbajh SE; Srebrow A; Kornblihtt AR
EMBO J; 2001 Oct; 20(20):5759-68. PubMed ID: 11598018
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activators differ in their abilities to control alternative splicing.
Nogues G; Kadener S; Cramer P; Bentley D; Kornblihtt AR
J Biol Chem; 2002 Nov; 277(45):43110-4. PubMed ID: 12221105
[TBL] [Abstract][Full Text] [Related]
4. Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer.
Cramer P; Cáceres JF; Cazalla D; Kadener S; Muro AF; Baralle FE; Kornblihtt AR
Mol Cell; 1999 Aug; 4(2):251-8. PubMed ID: 10488340
[TBL] [Abstract][Full Text] [Related]
5. RNA polymerase II C-terminal domain mediates regulation of alternative splicing by SRp20.
de la Mata M; Kornblihtt AR
Nat Struct Mol Biol; 2006 Nov; 13(11):973-80. PubMed ID: 17028590
[TBL] [Abstract][Full Text] [Related]
6. Influence of polymerase II processivity on alternative splicing depends on splice site strength.
Nogués G; Muñoz MJ; Kornblihtt AR
J Biol Chem; 2003 Dec; 278(52):52166-71. PubMed ID: 14530256
[TBL] [Abstract][Full Text] [Related]
7. Control of alternative pre-mRNA splicing by RNA Pol II elongation: faster is not always better.
Nogués G; Kadener S; Cramer P; de la Mata M; Fededa JP; Blaustein M; Srebrow A; Kornblihtt AR
IUBMB Life; 2003; 55(4-5):235-41. PubMed ID: 12880204
[TBL] [Abstract][Full Text] [Related]
8. Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a "portable enhancer domain"?
Seipel K; Georgiev O; Gerber HP; Schaffner W
Mol Reprod Dev; 1994 Oct; 39(2):215-25. PubMed ID: 7826625
[TBL] [Abstract][Full Text] [Related]
9. A slow RNA polymerase II affects alternative splicing in vivo.
de la Mata M; Alonso CR; Kadener S; Fededa JP; Blaustein M; Pelisch F; Cramer P; Bentley D; Kornblihtt AR
Mol Cell; 2003 Aug; 12(2):525-32. PubMed ID: 14536091
[TBL] [Abstract][Full Text] [Related]
10. Effects of repetitive and non-repetitive rat rDNA enhancer elements on in vivo transcription by RNA polymerases I and II.
Ghosh AK; Kermekchiev M; Jacob ST
Gene; 1994 Apr; 141(2):271-5. PubMed ID: 8163201
[TBL] [Abstract][Full Text] [Related]
11. cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing.
Liao HJ; Baker CC; Princler GL; Derse D
Virology; 2004 May; 323(1):131-40. PubMed ID: 15165825
[TBL] [Abstract][Full Text] [Related]
12. Novel exploitation of a nuclear function by influenza virus: the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells.
Shih SR; Krug RM
EMBO J; 1996 Oct; 15(19):5415-27. PubMed ID: 8895585
[TBL] [Abstract][Full Text] [Related]
13. A novel bipartite splicing enhancer modulates the differential processing of the human fibronectin EDA exon.
Caputi M; Casari G; Guenzi S; Tagliabue R; Sidoli A; Melo CA; Baralle FE
Nucleic Acids Res; 1994 Mar; 22(6):1018-22. PubMed ID: 8152907
[TBL] [Abstract][Full Text] [Related]
14. A polar mechanism coordinates different regions of alternative splicing within a single gene.
Fededa JP; Petrillo E; Gelfand MS; Neverov AD; Kadener S; Nogués G; Pelisch F; Baralle FE; Muro AF; Kornblihtt AR
Mol Cell; 2005 Aug; 19(3):393-404. PubMed ID: 16061185
[TBL] [Abstract][Full Text] [Related]
15. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.
Gallego ME; Gattoni R; Stévenin J; Marie J; Expert-Bezançon A
EMBO J; 1997 Apr; 16(7):1772-84. PubMed ID: 9130721
[TBL] [Abstract][Full Text] [Related]
16. Functional association between promoter structure and transcript alternative splicing.
Cramer P; Pesce CG; Baralle FE; Kornblihtt AR
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11456-60. PubMed ID: 9326631
[TBL] [Abstract][Full Text] [Related]
17. Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors.
Weng J; Ma W; Mitchell D; Zhang J; Liu M
J Cell Biochem; 2005 Dec; 96(5):1034-48. PubMed ID: 16149059
[TBL] [Abstract][Full Text] [Related]
18. Simian virus 40 enhancer increases RNA polymerase density within the linked gene.
Weber F; Schaffner W
Nature; 1985 May 2-8; 315(6014):75-7. PubMed ID: 2986014
[TBL] [Abstract][Full Text] [Related]
19. Dynamic enhancer-gene body contacts during transcription elongation.
Lee K; Hsiung CC; Huang P; Raj A; Blobel GA
Genes Dev; 2015 Oct; 29(19):1992-7. PubMed ID: 26443845
[TBL] [Abstract][Full Text] [Related]
20. PLP1 alternative splicing in differentiating oligodendrocytes: characterization of an exonic splicing enhancer.
Wang E; Huang Z; Hobson GM; Dimova N; Sperle K; McCullough A; Cambi F
J Cell Biochem; 2006 Apr; 97(5):999-1016. PubMed ID: 16288477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
